BioNTech SE (BNTX) vs Mettler-Toledo International Inc. (MTD)
A side-by-side comparison of BioNTech SE and Mettler-Toledo International Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 20, 2026. Differences are shown without an overall score or investment verdict.
BNTX
BioNTech SE
$113.12HealthcareDelayed quote: Aug 19, 2026, 4:00 PM EDT
MTD
Mettler-Toledo International Inc.
$1,425.09HealthcareAt close: Aug 19, 2026, 4:00 PM ET
Total return — BNTX vs MTD
growth of $100 · dividends reinvested · last 7yBNTX +705.0% (+34.7%/yr)MTD +114.8% (+11.5%/yr)BNTX compounded faster over this window
BNTX MTD
BNTX vs MTD: by the numbers
- •MTD is the larger company ($28.80B vs $28.42B market cap).
- •MTD is profitable (21.91% net margin) while BNTX runs a net loss (-62.98%).
- •BNTX grew revenue faster over the past five years (40.61% vs 3.54% CAGR).
Metrics side by side
Valuation
| Metric | BNTX | MTD |
|---|---|---|
| P/E ratio | N/A | 32.03 |
| Forward P/E | N/A | 30.26 |
| P/S ratio | 9.25 | 6.95 |
| P/B ratio | 1.41 | 2241.19 |
| EV / EBITDA | N/A | 23.38 |
| FCF yield | 2.16% | 3.01% |
Profitability
| Metric | BNTX | MTD |
|---|---|---|
| Gross margin | 70.98% | 59.30% |
| Operating margin | -22.63% | 28.69% |
| Net margin | -62.98% | 21.91% |
| ROE | -9.62% | 7062.40% |
| ROIC | -10.37% | 38.57% |
Growth (annualized)
| Metric | BNTX | MTD |
|---|---|---|
| Revenue CAGR (5Y) | 40.61% | 3.54% |
| EPS CAGR (5Y) | N/A | 10.81% |
| FCF CAGR (5Y) | N/A | 2.13% |
| Total return CAGR (5Y) | -19.15% | -1.56% |
Frequently asked
- Which has grown faster, BNTX or MTD?
- Over the past five years, BNTX grew revenue faster — BNTX at a 40.61% CAGR versus MTD at 3.54%.
- Is BNTX or MTD more profitable?
- MTD runs the higher net margin — BNTX at -62.98% versus MTD at 21.91%.
- How have BNTX and MTD total returns compared?
- Over the past 5 years, BNTX delivered -19.15% and MTD delivered 13.33% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Mettler-Toledo International P/E ratioBioNTech SE ROEMettler-Toledo International ROEBioNTech SE operating marginMettler-Toledo International operating marginBioNTech SE revenue growthMettler-Toledo International revenue growthBioNTech SE free cash flowMettler-Toledo International free cash flow
BioNTech SE & Mettler-Toledo International appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 20, 2026.